Skip to content

Nutritional Assessment in Individuals with Liver Cirrhosis

Nutritional Assessment in Individuals with Liver Cirrhosis (Nutri-CIRR)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06588712
Acronym
Nutri-CIRR
Enrollment
1000
Registered
2024-09-19
Start date
2024-10-31
Completion date
2029-04-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Brief summary

The risk factors for liver cirrhosis are well identified and primarily include excessive and prolonged alcohol consumption, as well as metabolic syndrome or infection with hepatitis B and C viruses. However, the factors that can predict the progression of the disease are still largely unknown. The role of nutritional factors, in particular, has been insufficiently studied in chronic liver diseases such as cirrhosis. Beyond malnutrition and nutritional deficiencies, whose roles have been well studied, it appears that other nutritional factors, such as adherence to dietary recommendations that consider the consumption of various food groups, have been little studied in patients with liver cirrhosis. Studies involving a large number of participants are essential to better describe the typical nutritional profiles of these patients, taking into account their diet, as well as their alcohol consumption and physical activity. Therefore, the main aim of the Nutri-CIRR project is to identify and characterize typical profiles of patients with hepatic cirrhosis in terms of nutritional factors (diet, alcohol consumption and physical activity) and smoking status.

Detailed description

The Nutri-CIRR study is an observational study taking place in France and assessing nutritional factors among patients with liver cirrhosis. After inclusion in the study, all patients are invited to complete validated online questionnaires on diet, alcohol consumption, physical activity, as well as socioeconomic and other lifestyle characteristics. Questionnaires are completed at one occasion. The main aim of the Nutri-CIRR project is to identify and characterize typical profiles of patients with hepatic cirrhosis in terms of nutritional factors (diet, alcohol consumption and physical activity) and smoking status. Secondary aims are: * Secondary aim #1: To describe values of the PNNS-GS2 score categorized into quantiles, which takes into account nutritional factors (diet, alcohol consumption and physical activity) * Secondary aim #2: To evaluate the associations between nutritional factors (diet, alcohol consumption, physical activity) and the subsequent occurrence of hepatocellular carcinoma * Secondary aim #3: To determine whether nutritional factors (diet, alcohol consumption, physical activity) are associated with competing hepatic risks (ascites, jaundice, bleeding due to portal hypertension, severe bacterial infections) and extra-hepatic risks (cardiovascular events, extra-hepatic cancers). To address secondary aims #2 and #3, data from the Nutri-CIRR study will be matched with data from the FASTRAK study (NCT05095714), which monitors the liver disease progression.

Interventions

None listed

Sponsors

Hôpital Henri Mondor, AP-HP, Unité de Recherche Clinique
CollaboratorUNKNOWN
Hôpital Avicenne, AP-HP, Service Hépatologie
CollaboratorUNKNOWN
Université Sorbonne Paris Nord
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients * Histologically proven cirrhosis or unequivocally suggested by non-invasive tests * No HCC on imaging dated less than 3 months * Ability to understand and read French, at the investigator's discretion * Affiliation with a social security system

Exclusion criteria

* Child-Pugh C score * Active hepatitis B or C * Patient under legal protection * Patient deprived of liberty * Pregnant or breastfeeding woman, as known by the investigator * Patient under State Medical Assistance (AME) * Patient opposed to participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Nutritional scoreAt enrollmentPNNS-GS2 is a nutritional score calculated using data on dietary intake, alcohol intake and physical activity. A higher score indicates a greater nutritional quality
Physical activityAt enrollmentDuration of moderate and vigorous physical activity, duration of walking, physical activity level (low, moderate, high, calculated using the duration of moderate, vigorous physical activity and walking), assessed with the IPAQ short-form
Sedentary behaviorAt enrollmentSitting time, assessed with the IPAQ short-form
WeightAt enrollmentSelf-reported body weight
HeightAt enrollmentSelf-reported height
Body mass indexAt enrollmentCalculated as weight/(height\*height)
Nutritional intakesAt enrollmentUsual macronutrient and micronutrient intakes, assessed with a validated food frequency questionnaire
Food group intakesAt enrollmentUsual intake of the main food groups, assessed with a validated food frequency questionnaire
Mediterranean diet scoreAt enrollmentMediterranean diet score, assessed with a validated food frequency questionnaire
Alcohol intakeAt enrollmentUsual alcohol intake, total and by type of alcoholic beverages, assessed with a validated food frequency questionnaire
Smoking statusAt enrollmentSmoking status, number of pack-years, assessed by questionnaire

Secondary

MeasureTime frameDescription
Demographic factorsAt enrollmentGender, marital status, household composition, number of children
Follow-up of cirrhotic disease (occurrence of hepatocellular carcinoma)From enrollment to the end of follow-up at 3 yearsOccurrence of hepatocellular carcinoma. These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK)
Follow-up of cirrhotic disease (other hepatic complications)From enrollment to the end of follow-up at 3 yearsOccurrence of other hepatic complications (ascites, jaundice, bleeding due to portal hypertension, severe bacterial infections). These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK)
Follow-up of cirrhotic disease (extra-hepatic complications)From enrollment to the end of follow-up at 3 yearsOccurrence of extra-hepatic complications (cardiovascular events, extra-hepatic cancers). These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK)
Socioeconomic factorsAt enrollmentEducational, level, occupation, income

Contacts

Primary ContactAlice Bellicha, PhD
a.bellicha@eren.smbh.univ-paris13.fr00(33)148388933
Backup ContactLaure Legris
laure.legris@eren.smbh.univ-paris13.fr00(33)148388933

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026